Radiopharm Theranostics (RADX) Total Debt (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Radiopharm Theranostics (RADX) has disclosed Total Debt for 2 consecutive years, with $32.1 million as the latest value for Q2 2025.

• On a quarterly basis, Total Debt fell 3.97% to $32.1 million in Q2 2025 year-over-year; TTM through Jun 2025 was $32.1 million, a 3.97% decrease, with the full-year FY2025 number at $32.1 million, down 3.97% from a year prior.
• Total Debt was $32.1 million for Q2 2025 at Radiopharm Theranostics, down from $33.4 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $33.4 million in Q2 2024 to a low of $32.1 million in Q2 2025.

Peer Comparison